For at minimere risikoen for nyreskader skal probenecidtabletter og intravenøs saltvandsopløsning indgives sammen med hver VISTIDE- infusion.
To minimise the potential for kidney damage, probenecid tablets and intravenous saline solution must be administered with each VISTIDE infusion.